← Open Payments lookup

JHOULEEN ANGELIKA TIAMZON: Open Payments

NPI 1306451471 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,579 in 110 payments from 18 companies in 2025. Trend: 2023 $1,373 · 2024 $2,604 · 2025 $2,579

Food & beverage: $2,572Education: $6
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.17$377
Travere Therapeutics, Inc.9$310
Novartis Pharmaceuticals Corporation12$287
Amgen Inc.10$258
Bayer Healthcare Pharmaceuticals Inc.10$229
Boehringer Ingelheim Pharmaceuticals, Inc.7$175
Vifor Pharma, Inc.11$169
Calliditas Therapeutics US Inc.7$169
ANI Pharmaceuticals, Inc.7$143
AKEBIA THERAPEUTICS INC4$104

Products named: Fabhalta, KRYSTEXXA, Kerendia, JYNARQUE, JARDIANCE, Veltassa, TARPEYO, PURIFIED CORTROPHIN GEL.

Industry payments across NV — which companies pay providers there.